This inventor holds 7 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Biora Therapeutics, Inc., Bt Bidco, Inc., Progenity, Inc.. Active years: 2021-2026.
Company Filing History:
4 out of 17 
2 out of 3 
1 out of 20 Years Active: 2021-2026
Title: Iman Niknia: Innovator in Ingestible Device Technology
Introduction
Iman Niknia is a prominent inventor based in Victoria, Canada, known for his groundbreaking work in the field of ingestible devices. With a total of five patents to his name, he has made significant contributions to the delivery of therapeutic agents directly to the gastrointestinal tract.
Latest Patents
Niknia's latest patents include an "Ingestible device for delivery of therapeutic agent to the gastrointestinal tract." This innovative device is designed to deliver therapeutic agents to specific tissues within the GI tract, such as the submucosa and mucosa, in a safe and effective manner. Another notable patent is the "Ingestible device for delivery of a dispensable substance," which focuses on devices capable of delivering therapeutic agents through a removably attachable storage reservoir.
Career Highlights
Throughout his career, Iman Niknia has worked with notable companies such as Biora Therapeutics, Inc. and Progenity, Inc. His work has been instrumental in advancing the field of ingestible technology, paving the way for new treatment methods.
Collaborations
Niknia has collaborated with several professionals in his field, including Mitchell Lawrence Jones and Mark Sasha Drlik. These partnerships have contributed to the development and refinement of his innovative devices.
Conclusion
Iman Niknia's contributions to the field of ingestible devices highlight his role as a leading inventor in medical technology. His patents reflect a commitment to improving therapeutic delivery methods, ultimately benefiting patients in need.